Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 06:11 am Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BALYASNY ASSET MANAGEMENT L.P. | 0 0% | -4,408,952 (Position Closed) | View |
| 2021-12-03 06:09 am Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BALYASNY ASSET MANAGEMENT L.P. | 4,408,952 5.67% | 4,408,952 (New Position) | View |
| 2021-02-12 3:36 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | EcoR1 Capital LLC | 0 0% | -3,627,597 (Position Closed) | View |
| 2021-02-12 10:01 am Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | RTW INVESTMENTS LP | 7,253,857 9.67% | 1,379,628 (+23.49%) | View |
| 2021-02-04 11:40 am Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | WELLINGTON MANAGEMENT GROUP LLP | 4,317,623 5.75% | 3,648,932 (+545.68%) | View |
| 2021-01-29 09:56 am Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BlackRock Inc. BLK | 6,034,729 8% | 1,601,639 (+36.13%) | View |
| 2020-12-14 5:25 pm Sale | 13D | DICERNA PHARMACEUTICALS INC CO DRNA | Bain Capital Life Sciences Fund L.P. | 2,786,247 3.7% | -904,556 (-24.51%) | View |
| 2020-02-14 4:34 pm Unchanged | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BRIDGER MANAGEMENT LLC | 1,981,633 2.9% | 0 (Unchanged) | View |
| 2020-02-14 4:06 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | Cormorant Asset Management LP | 0 0% | -3,481,471 (Position Closed) | View |
| 2020-02-14 4:04 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BRIDGER MANAGEMENT LLC | 1,981,633 2.9% | -2,792,085 (-58.49%) | View |
| 2020-02-14 2:27 pm Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | EcoR1 Capital LLC | 3,627,597 5.3% | 311,190 (+9.38%) | View |
| 2020-02-14 1:34 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | RTW INVESTMENTS LP | 5,874,229 8.58% | -32,859 (-0.56%) | View |
| 2020-02-05 11:46 am Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BlackRock Inc. BLK | 4,433,090 6.5% | 101,862 (+2.35%) | View |
| 2019-12-06 5:11 pm Sale | 13D | DICERNA PHARMACEUTICALS INC CO DRNA | Bain Capital Life Sciences Fund L.P. | 3,690,803 5.4% | -1,356,834 (-26.88%) | View |
| 2019-11-21 4:27 pm Sale | 13D | DICERNA PHARMACEUTICALS INC CO DRNA | Bain Capital Life Sciences Fund L.P. | 5,047,637 7.4% | -1,582,973 (-23.87%) | View |
| 2019-05-31 4:00 pm Sale | 13D | DICERNA PHARMACEUTICALS INC CO DRNA | Bain Capital Life Sciences Fund L.P. | 6,630,610 9.7% | -1,447,289 (-17.92%) | View |